M
onocytes are critical to the development of atherosclerosis, and inhibition of monocyte development or trafficking strongly impairs atherosclerotic lesion formation. [1] [2] [3] Monocytederived macrophages accumulate in the plaque and transform into lipid-loaded foam cells, often committed to death. In early plaques, when phagocytic clearance of apoptotic cells (efferocytosis) is optimal, apoptosis is beneficial and helps limit lesion development. In the later stages of atherosclerosis, when efferocytosis is deregulated, necrosis secondary to apoptosis promotes plaque inflammation and lesion progression. 4 Currently, several types of monocyte subsets have been described and are thought to have divergent functions. In mice, classical Ly-6C hi CCR2 + (C-C motif chemokine receptor 2) monocytes (C-Mo) migrate to sites of injury where they differentiate into inflammatory macrophages. C-Mo dominate hypercholesterolemia-associated monocytosis and macrophage accumulation in the plaque. 5 In contrast, Ly-6C lo CX3CR1
hi (CX3C chemokine receptor 1) nonclassical monocytes (NC-Mo) exhibit a unique ability to patrol the vasculature and remove damaged cells and debris. 6 In atherosclerosis, the exact role of NC-Mo is not fully understood. Recent studies suggested that their patrolling along the vascular wall limit vascular inflammation and early atherogenesis. 7, 8 The transcription factor NR4A1 (nuclear receptor subfamily 4 group A member 1) is absolutely required for NC-Mo development, and mice deficient for NR4A1 lack NC-Mo and accumulate M1-like macrophages in the plaque, favoring accelerated atherosclerosis. 9 However, in another study, the lack of NR4A1 had no impact on macrophage polarization and did not change atherosclerosis. 10 More recently, E2 domain-deficient Ldlr −/− (low-density lipoprotein receptor) mice which lack Ly6C lo monocytes but retain Nr4a1 gene expression in macrophages were shown to have accelerated atherosclerosis. 8 The chemokine receptor CX3CR1 also contribute to NC-Mo survival and the absence of CX3CR1, which impairs NC-Mo number in blood of ApoE −/− (apolipoprotein E) or Ldlr −/− mice, protected mice against atherosclerosis. 11, 12 The discrepancy between these studies highlights the need to identify key molecular mechanisms underlying maintenance of monocyte subsets. MicroRNAs are well conserved, short noncoding RNAs known to play major roles in most biological processes by influencing the stability and translation of mRNAs. 13 MicroRNA-21 (miR-21) plays important roles in leukocyte function, driving both cell polarization and survival, particularly, during inflammatory conditions. 14-16 miR-21 has been linked to several cardiovascular diseases and highly correlates with the evolution of multiple cancers. A recent study reported that deletion of miR-21 in the hematopoietic compartment of LDLr −/− mice on high-fat diet (HFD) accelerated the development of advanced atherosclerosis in part through accumulation of inflammatory macrophages and defective efferocytosis. 17 Here, we aimed to investigate the role of miR-21 on homeostasis of monocytes in ApoE −/− mice and its effect in early and advanced stages of atherosclerosis.
Materials and Methods
All supporting data are available within the article (and in the onlineonly Data Supplement). ) of the same age and sex were used as control. Because sexual dimorphisms have been reported in atherosclerosis studies, 18 particularly when comparing early and advanced atherosclerosis, 19 we used 1 sex to minimize the number of mice used in the study and chose males as in Canfrán-Duque et al 17 and Jin et al.
Animals
20 B6-Ly5.1/Cr mouse, which carry the allele CD45.1 were purchased from Charles River and crossed to ApoE −/− mice to generate ApoE −/− CD45.1 mice. All mice used in these experiments were bred and housed in a specific pathogen-free barrier facility. Mice were either maintained on chow diet or put on a proatherogenic HFD (15% fat, 1.25% cholesterol) as mentioned in the figure legends.
Flow Cytometry and Cell Sorting Assessment
Total blood has been collected on heparin or EDTA tubes before counting and staining. Mice were perfused with PBS before organ removal. The spleen was dissociated, and the bone marrow flushed. Cells were filtered and counted before staining.
Blocking of nonspecific binding of immunoglobulin to Fc receptors was done with a purified anti-mouse CD16/32 antibody. Leukocyte population was identified using the following antibodies: anti-CD11b (M1/70), anti-CD115 (AFS98), anti-Gr1 (RB6-8C5), anti-CD4 (RM4-5), anti-CD3 (145-2C11), anti-CD8 (53-6.7), anti-CD62L (MEL-14), Anti-CD44 (IM7) anti-B220 (RA3-6B2), and anti-NK1.1 (PK136). Chemokines receptors were stained using an anti-CCR2 (FAB5538P) and anti-CX3CR1 (SA011F11 RNA from high and low monocytes were isolated using the RNeasy MicroKit (Qiagen, Deutschland) according to the manufacturer's instructions and frozen at −80°C.
For the miRNA (microRNA) reverse transcription, 5 ng/μL of isolated RNA was used with the miRCURY LNA Universal RT microRNA PCR (Exiqon A/S, Denmark). Real-time quantitative polymerase chain reaction was performed with SYBER GREEN reagent (Eurogentec), using miR-21-5p and miR-21-3p (Exiqon A/S, Denmark) primer. miR-21 expression was normalized to U6, 5S, and RNU5G (Exiqon A/S, Denmark) genes as references. Analysis was runned with ABI PRISM thermocycler. Relative expression was calculated using the 2-deltadelta CT method followed by geometric average, as recommended. 21 For the total mRNA reverse transcription, 100 ng/μL of isolated RNA was used with the QuantiNova Reverse Transcription Kit (Qiagen, Deutschland). Real-time quantitative polymerase chain reaction was operated with SYBER GREEN Reagent, using the following mouse primers: CX3CR1 5'-GGAGTCTGCGTGAGACTGGGTGAGTGA-3' and 5'-GAGGGCGTAGAAGACGGACAGGAAGATG-3', Nur77 5'-GTCCTGGAGCCCGTGTCGATCA-3' and 5'-TTCCCGCCTTT GCCTGCCTGT-3', CCR2 5'-GCCGTGGATGAACTGAGGTAACA-3' and 5'-GAGGGCATTGGATTCACCACA-3', CCR5 5'-GGCAGGAGC TGAGCCGCAATTTGTTT-3' and 5'-GGTGAGACATCCGTTCCCCC TACAAGA-3', CXCR4 5'-CTGAGGCGTTTGGTGCTCCGGTAA-3' and 5'-ATCCCGGAAGCAGGGTTCCTTGT-3'. Relative expression of these genes was calculated using the ΔΔCT method, using the GAPDH 5'-CGTCCCGTAGACAAAATGGTGAA-3' and 5'GCCGTGA GTGGAGTCATACTGGAACA-3' as reference gene.
Bone Marrow-Derived Macrophages and Apoptosis Assay In Vitro
Primary macrophages were derived from mouse bone marrow-derived cells. Tibias and femurs of mice were dissected and their marrow flushed out. Cells were grown for 7 days at 37°C in a solution of RPMI (Roswell Park Memorial Institute medium) 1640 medium, 20% neonatal calf serum, and 20% macrophage-colony-stimulating factor-rich L929-conditioned medium. To analyze apoptosis susceptibility, untreated bone marrow-derived cells were incubated with FCS-free medium, TNF (tumor necrosis factor)-α (10 μg/mL), and cycloheximide (10 μM), or etoposide (50 μg/mL) for 12 hours. Apoptosis was determined by using Annexin V fluorescein isothiocyanate apoptosis detection kit with 7-AAD (7-aminoactinomycin D; APC; BD Biosciences, San Jose, CA) according to the manufacturer's instructions. 
Bone Marrow Transplantation

For the Competition Assay
Eight-week-old male Apoe −/− CD45.2 mice were lethally irradiated (9.5 Gray) and intravenously reconstituted with 10 million cells coming from a 1:1 bone marrow cell mix of ApoE −/− CD45. Height weeks after reconstitution, blood samples were taken from mice maintained under isoflurane anesthesia to test the chimerism.
For Atherosclerosis Quantification
Eight-week-old male Apoe −/− mice were lethally irradiated (9.5 Gray) and intravenously reconstituted with 10 million cells coming from 
Quantification of Atherosclerotic Lesions
Mice were anesthetized with isoflurane before sacrifice. Plasma cholesterol was measured using a commercial kit (DiaSys Cholesterol FS*, Germany). Quantification of lesion size and composition was performed as previously described 22 and is in agreement with the recent recommendation. 23 Briefly, the heart and ascending aorta were removed, perfusion-fixed in situ with 4% paraformaldehyde, then placed in PBS-30% sucrose solution overnight, before being embedded in frozen optimal cutting temperature compound and frozen at −70°C. Afterward, 10-mm serial sections of aortic sinus were obtained (cut on cryostat). Lipids were detected using Oil Red O (Sigma-Aldrich, St Louis, MO) coloration and quantified by a blinded operator using HistoLab software (Microvision Instruments, Paris, France) 30, which was also used for morphometric studies. For lesion size quantification, multiple sections in multiple regions were analyzed. For tissue characteristics, same regions of the aortic sinus were used between animals. En face quantification was used for atherosclerotic plaques along thoraco-abdominal aorta, as previously described. 22 Collagen was detected using Sirius red staining. The presence of macrophages was determined using monoclonal rat anti-mouse macrophage/monocyte antibody 2 (MAB1852). Apoptotic macrophages in the lesion were identified as anti-mouse macrophage/monocyte antibody 2 + TUNEL + (terminal deoxynucleotidyl transferase dUTP nick-end labeling; Roche) or as cleaved-caspase 3 + (5A1E). CD206, and MHCII stainings were done with anti-CD206 (C068C2) and anti-MHCII (M5/114.15.2) antibodies.
At least 4 sections per mouse were examined for each immunostaining, and appropriate negative controls were used.
Monocyte Labeling In Vivo
NC-Mo were labeled in vivo by retro-orbital intravenous injection of 1 μm fluorescent microsphere (YG, Polysciences) diluted 1⁄4 in sterile PBS. Cell labeling was checked 24 hours later by flow cytometry. The recruitment of bead + labeled NC-Mo was quantified in the aorta, 5 days after labeling by counting the number of beads in the digested aorta, by flow cytometry. For staining on aortic cells, the aorta was removed and flushed intensively with 2 mmol/L 0.2% FBS PBS. The aorta was cut into pieces and digested using a cocktail of enzymes for 45 minutes at 37°C (450 U/mL collagenase I, 125 U/mL collagenase XI, 60 U/mL hyaluronidase I; all from Sigma-Aldrich).
Thioglycollate Assay
Mice were injected intraperitoneally with 1 mL 3% thioglycollate. Peritoneal cells were harvested by successive lavages with cold PBS EDTA 0.5 μM.
Efferocytosis Assay In Vivo
Five males miR-21 +/+ and 5 males miR-21 −/− of 8 weeks were injected intraperitoneally with 2 mL of 3% thioglycollate. Forty-eight hours after, thymocytes from 4 weeks old C57Bl6 male mice were isolated, stained with CFSE (carboxyfluorescein succinimidyl ester; 5 μM) for 5 minutes at 37°. The reaction was stopped by adding cold FCS and washed twice with sterile PBS. Apoptosis of thymocytes was induced by exposing the cells to UV radiation (0.25 J/min) for 10 minutes. Apoptosis was controlled by flow cytometry (Annexin V-7AAD staining). Ten million apoptotic thymocytes were injected intraperitoneally (1 mL) to mice treated with thioglycollate. 
Statistical Analysis
Values are expressed as mean±SEM. Differences between values were evaluated using nonparametric Mann-Whitney test or other as specified in the legends. All these analyses were performed using GraphPad Prism version 5.0b for Mac (GraphPad Software), and values were considered significant at P<0.05. Figure 1B) , suggesting that miR-21-5p might differently control the homeostasis of monocyte subsets. In contrast, miR-21-3p expression was below detection in all other circulating leukocyte subsets (not shown).
We investigated the impact of miR-21 in monocyte subsets by exploring the expression of genes involved in cell survival and migration. In the absence of miR-21, NC-Mo showed decreased Nr4a1 and Cx3cr1 mRNA expression ( Figure 1C Figure 1D ). miR-21 deficiency was associated with increased Phospho-P38 MAP kinase and decreased CD115 expression in circulating NC-Mo, but not in C-Mo ( Figure 1D and Figure 
miR-21 Deficiency Transiently Delays the Development of Atherosclerosis in ApoE −/− Mice
We then explored the role of miR-21 at various stages of atherosclerosis development in ApoE −/− mice. In early atherosclerosis, at 10 weeks of age, the absence of miR-21 had no major impact on atherosclerosis lesion development or composition in ApoE −/− mice ( Figure VA and VB in the online-only Data Supplement). At 24 weeks of age, the absence of miR-21 reduced atherosclerotic lesion size, both in the thoracic aorta and the aortic root (Figure 2A and 2B ). In the absence of miR-21, macrophage content was unchanged ( Figure 2C ), but the amount of TUNEL + apoptotic macrophages was increased in lesions ( Figure 2D ). At this stage, smooth muscle cell accumulation and necrotic area extent were not altered (not shown). In vitro, we found that the lack of miR-21 increased the susceptibility of macrophages to apoptosis (Figure VIA in the onlineonly Data Supplement), which substantiates our in vivo data. In addition, we found that miR-21 −/− macrophages became more inflammatory in plaques, as evidenced by the changes in CD206 and iNOS (inducible nitric oxide synthase) expression ( Figure 2E ). We confirmed that the absence of miR-21 broadly polarized macrophages to an M1-like signature (CD206   -MHCII hi (major histocompatibility complex class II); Figure  VIB in the online-only Data Supplement). We also examined the role of miR-21 on monocyte migration in vivo. C-Mo recruitment was tested in a model of sterile peritonitis in the mixed BM chimeras presented in Figure 1F . We found similar chimerism of monocytes/macrophages in the blood before and in the peritoneum after thioglycollate injection, suggesting that the absence of miR-21 had no impact on C-Mo trafficking in vivo ( Figure VIIA in the online-only Data Supplement). The recruitment of NC-Mo was quantified in the atherosclerotic aorta with a pulse-labeling method. 24 We found a decrease of bead + NC-Mo in the aorta of mice deficient for miR-21 ( Figure 2F ), which could most likely be attributed to less NC-Mo in blood. Altogether, these data show that miR-21 deficiency decreases NC-Mo availability in blood, orientates plaque macrophages toward an inflammatory profile, and increases their susceptibility to apoptosis. These concomitant events limit early atherosclerosis formation in ApoE Figure VIIID and VIIIE in the online-only Data Supplement). The amount of TUNEL + apoptotic macrophages in lesions was increased, and similar data were obtained using activated caspase-3 as an assay for lesional apoptosis ( Figure IXA in the online-only Data Supplement). Neutral lipid and collagen contents were unchanged ( Figure  IXB in the online-only Data Supplement). Because necrotic core development likely occurs through the combination of defective efferocytosis and enhanced macrophage death, we examined the role of miR-21 on efferocytosis in vivo. The absence of miR-21 decreased by almost 2-fold the capacity of peritoneal macrophages to engulf CFSE-labeled apoptotic thymocytes ( Figure 2G ), in agreement with recent findings. 18 We additionally examined the specific contribution of myeloid-derived miR-21 in atherosclerosis development by performing BMT. The absence of miR-21 in the hematopoietic compartment reduced plaque size when mice were kept on chow diet for 12 weeks after BMT ( Figure 2H ) but had no effect when mice were fed an HFD for 10 weeks after BMT ( Figure  XA in the online-only Data Supplement). As expected, the level of blood NC-Mo was decreased (Figure XB in the online-only Data Supplement). These results strengthen our conclusion that miR-21 deficiency impacts NC-Mo homeostasis, which at least in part contributes to limit early-stage atherosclerosis.
Discussion
The purpose of this study was to investigate the role of miR-21 in homeostasis of monocytes in ApoE −/− mice. RNA-based therapeutics have demonstrated great promise for the treatment of different diseases, and miR-21 is an interesting target as it regulates macrophage polarization, apoptosis, and efferocytosis. 15 Here, we report that miR-21 expression is increased in circulating NC-Mo from ApoE −/− mice on chow or HFD, compared with C-Mo. miR-21 deficiency in ApoE −/− mice significantly altered the amount of circulating NC-Mo, which could be accounted for by decreased NC-Mo longevity as shown by our in vivo experiments. We analyzed the role of miR-21 on atherosclerosis development in ApoE −/− mice, at 3 different stages of the disease. miR-21 deficiency partially protected against early development of atherosclerosis (at 10 and 24 weeks of age), despite the tendency of plaque macrophages to be more inflammatory and more susceptible to apoptosis. In contrast, at later stages of atherosclerosis (after 10 weeks on HFD), lesion size in the aortic root was similar in ApoE −/− and ApoE −/− miR-21 −/− mice but less stable (larger necrotic core) in the latter. Using BMT, we found that the protection conferred in the absence of miR-21, in early atherosclerosis, was related to the hematopoietic compartment. Our interpretation is that the absence of miR-21, concomitant limitation of monocyte-derived macrophage influx in the forming lesion and increased apoptosis of local macrophages protected against early atherosclerosis formation. The loss of protection in more advanced stages is most likely because of excessive inflammatory apoptosis because of impaired efferocytosis and to possible minor recruitment of NC-Mo in lesions under 20 which contrasts with our present findings. One unexplained result from that study 20 is that 16-week-old ApoE −/− mice had no detectable atherosclerotic lesions in the thoracic aorta.
Our observation that miR-21 controls the survival of NC-Mo are important for several reasons. First, considering that monocyte subsets are committed to divergent functions, there is a need to identify specific factors that regulate the balance between C-Mo and NC-Mo in pathophysiological conditions. Recently, miR-146a was identified as a specific regulator of C-Mo responses during inflammatory challenges, without NC-Mo modifications. 25 Targeting miR-146 and miR-21 may then serve to limit the expansion and function of selective monocyte subsets. Second, human studies have underscored the relevance of studying monocyte subsets because an imbalance in their relative proportion is linked to several diseases. 26 For instance, increased proportions of NC-Mo have been reported in patients with inflammatory conditions, including sepsis and rheumatoid arthritis. [27] [28] [29] In atherosclerosis, the function, as well as time course and spatial distribution of NC-Mo are still unclear. In a previous study in ApoE −/− mice on chow diet for 25 weeks, we found that NC-Mo may significantly contribute to lesion formation, at least under moderate hypercholesterolemia. 1 Our current work in ApoE −/− mice on chow and HFD supports this finding. A recent study suggested an antiatherogenic role of NC-Mo under massive hypercholesterolemia, in ldlr −/− mice under HFD for 15 weeks. 8 The properties and functions of NC-Mo may then differ according to the experimental settings and may account for the discrepancies between our work and that of Canfrán-Duque et al. 17 The fact that miR-21 expression increases in NC-Mo could explain their longer longevity as compared to C-Mo. The mechanisms whereby miR-21 regulates the cell death effector pathways in NC-Mo and whether hypercholesterolemia dictates the longevity of NC-Mo through the increase of miR-21 expression need further investigation. We did not find any effect of miR-21 deficiency on monocyte migration, despite the decrease in CX3CR1 expression. We cannot exclude a role of miR-21 on NC-Mo patrolling in large arteries, even though this property was shown to be CX3CR1 independent. 7, 8 It is also unlikely that miR-21 deficiency has altered NC-Mo production as it is now well accepted that NC-Mo monocytes derive directly from the C-Mo. 30 -32 Yet, we cannot rule out the possibility that the conversion of C-Mo into NC-Mo in blood was partially altered since C-Mo count in blood was unchanged despite a reduction of C-Mo in the bone marrow.
Finally, we have not addressed the potential contribution of miR-21 to atherosclerosis through other cell types, particularly T lymphocyte activation 33 and smooth muscle cell proliferation. 20, 34 In summary, the data herein shed light on a previously unknown role of miR-21 in the homeostasis of NC-Mo in ApoE −/− mice and brings new evidence on the role of miR-21 in atherosclerosis development.
